In earlier stages of CKD, PTH and FGF-23 (fibroblast growth factor 23) activity is sufficient to maintain normal levels of serum phosphorus by increasing the fractional excretion of phosphorus to compensate for decreasing renal function. Here, FGF23 is linked to chronic kidney disease.